SOLV Stock Analysis: Buy, Sell, or Hold?
SOLV - Solventum Corporation
$76.97
0.45 (0.59%)
▲
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When SOLV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called SOLV this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: SOLV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: SOLV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$101.91
Based on 4.7% avg growth
INTRINSIC VALUE TODAY
$63.28
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: SOLV is currently trading at $76.97, which is considered oversold relative to its 30-day fair value range of $78.37 to $83.11. The stock's valuation (Forward PE: 12.1) is in line with its historical norms (12.8). Remarkably, the market is currently pricing in an annual earnings decline of 1.8% over the next few years. This pessimistic expectation contrasts with the company's recent 931.4% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, SOLV is in a strong uptrend. The price is currently testing key support at $75.61. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SOLV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $89.25 (+16.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SOLV is in a strong uptrend. The price is currently testing key support at $75.61. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: SOLV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $89.25 (+16.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$78.37 -
$83.11
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
54.8%
Protect Your Profits
Holding SOLV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($89.25)
Fair Price Analysis
30-Day Fair Range
$78.37 -
$83.11
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$75.61
Resistance Level
$81.75
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
12.06
Wall Street Target
$89.25
(+16.6%)
Revenue Growth (YoY)
0.7%
Earnings Growth (YoY)
931.4%
Profit Margin
18.1%
Valuation Discount vs History
-1.8% cheaper
PE vs Historical
12.1 vs 12.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.8%
(market-implied from PE analysis)
1-Year Target
$75.14
(-2%)
2-Year Target
$73.79
(-4%)
3-Year Target
$72.46
(-5%)
3-Yr Target (if PE normalizes)
(PE: 12→13)
$76.89
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.3, Growth: 5.3%)
$165.23
(+116%)
Base:
(SPY PE: 12.1, Growth: 5.3%)
$89.38
(+17%)
Bear:
(PE: 10.3, Growth: 5.3%)
$75.97
(-1%)
📈
Valuation based on Current Earnings
Trailing PE: 8.79 | Current EPS (TTM): $8.71
Bull Case
$61.37
(-20%)
Analyst growth -27.2%, PE expands to 9.7
Base Case
$55.79
(-28%)
Market implied -27.2%, PE stable at 8.8
Bear Case
$52.09
(-32%)
Severe decline -20.0%, PE contracts to 7.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.1 to 12.8
Stabilization Target:
$81.20
(+6.1%)
PE Expansion Potential:
+6.1%
Last updated: January 31, 2026 1:01 AM ET
Data refreshes hourly during market hours. Next update: 2:01 AM
Data refreshes hourly during market hours. Next update: 2:01 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SOLV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Co 3M
SELL
8800000 shares
2025-08-15
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$92 | 63 BUY |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$608 | 58 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$191 | 58 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$292 | 57 HOLD |
|
ALGN
Align Technology Inc |
BUY
18 analysts |
$184 | 62 BUY |
Advanced SOLV Option Strategies
Professional options setups generated by AI based on today's SOLV price and gamma walls.
